A Randomized, Double-Blind Study of the Effect of Oral Monthly Bonviva on in Vivo Bone Micro-Architecture Parameters in Post-Menopausal Women With Osteopenia.
Phase of Trial: Phase III
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Bone resorption
- Focus Therapeutic Use
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
- 26 May 2010 Status changed from active, no longer recruiting to completed as reported by Roche record
- 25 May 2010 Actual number of patients (150) added as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History